×

Valuing Valeant

3:41 PM ET Thu, 21 April 2016

Aswath Damodaran, Professor of Finance Education at NYU Leonard N. Stern School of Business who is also known as the "Dean of Valuation," discusses Valeant Pharmaceuticals' valuation and why he thinks it is still a good investment.